Institutional
AIHC Capital Management Ltd
CIK 0002103725
$119.7M
Reported AUM
5
Positions
Q1 2026
Period
2026-05-08
Filed
The Brief · AIHC Capital Management Ltd · Q1 2026
AI · grounded in 13F
AIHC Capital Management Ltd established a new position in ORIC valued at $31.16M. The fund closed its positions in PTGX, reducing exposure by $16.58M, and AVBP, reducing exposure by $12.97M. Additionally, the fund increased its stake in NBP by 446.63% while trimming shares of COGT by 48.60%.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | $192.17 | 6.22% | 424.62% | 560.61% | $80.6M | 67.37% | — | HELD |
| 2 | ORIC | ORIC PHARMACEUTICALS INC | $11.64 | 3.19% | 15.02% | -47.31% | $31.2M | 26.04% | — | HELD |
| 3 | NBP | NOVABRIDGE BIOSCIENCES | $1.64 | 1.86% | -37.40% | -97.69% | $5.6M | 4.65% | — | HELD |
| 4 | COGT | COGENT BIOSCIENCES INC | $41.36 | 4.52% | 257.28% | 391.91% | $2.0M | 1.65% | — | HELD |
| 5 | KRRO | KORRO BIO INC | $10.45 | 3.77% | -24.55% | -97.29% | $343K | 0.29% | — | HELD |
Source: SEC EDGAR · accession 0001172661-26-001629. 13F discloses long positions only — shorts, foreign equities, and options are excluded.